<?xml version="1.0" encoding="UTF-8"?>
<front xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.0/xsd/JATS-journalpublishing1.xsd">
	<journal-meta>
		<journal-id journal-id-type="publisher-id">ECAM</journal-id>
		<journal-title-group>
			<journal-title>Evidence-Based Complementary and Alternative Medicine</journal-title>
		</journal-title-group>
		<issn pub-type="epub">1741-4288</issn>
		<issn pub-type="ppub">1741-427X</issn>
		<publisher>
			<publisher-name>Hindawi Publishing Corporation</publisher-name>
		</publisher>
	</journal-meta>
	<article-meta>
		<article-id pub-id-type="other">613737</article-id>
		<article-id pub-id-type="doi">10.1155/2011/613737</article-id>
		<article-id pub-id-type="publisher-id">613737</article-id>
		<article-categories>
			<subj-group subj-group-type="heading">
				<subject>Research Article</subject>
			</subj-group>
		</article-categories>
		<title-group>
			<article-title>Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula)</article-title>
		</title-group>
		<contrib-group>
			<contrib contrib-type="author" id="U98287623">
				<name>
					<surname>Zhang</surname>
					<given-names>Haojun</given-names>
				</name>
				<email>zhhj529@163.com</email>
				<xref ref-type="aff" rid="I1">
					<sup>1</sup>
				</xref>
			</contrib>
			<contrib contrib-type="author" id="U83780219" corresp="yes">
				<name>
					<surname>Li</surname>
					<given-names>Ping</given-names>
				</name>
				<email>lp8675@yahoo.com.cn</email>
				<xref ref-type="aff" rid="I1">
					<sup>1</sup>
				</xref>
			</contrib>
			<contrib contrib-type="author" id="U60903569">
				<name>
					<surname>Burczynski</surname>
					<given-names>Frank J.</given-names>
				</name>
				<email>burczyn@cc.umanitoba.ca</email>
				<xref ref-type="aff" rid="I2">
					<sup>2</sup>
				</xref>
			</contrib>
			<contrib contrib-type="author" id="U56380120">
				<name>
					<surname>Gong</surname>
					<given-names>Yuewen</given-names>
				</name>
				<email>ygong@cc.umanitoba.ca</email>
				<xref ref-type="aff" rid="I2">
					<sup>2</sup>
				</xref>
			</contrib>
			<contrib contrib-type="author" id="U65381274">
				<name>
					<surname>Choy</surname>
					<given-names>Patrick</given-names>
				</name>
				<email>pchoy@cc.umanitoba.ca</email>
				<xref ref-type="aff" rid="I3">
					<sup>3</sup>
				</xref>
			</contrib>
			<contrib contrib-type="author" id="U74818172">
				<name>
					<surname>Sha</surname>
					<given-names>Hong</given-names>
				</name>
				<email>shahong1cn@yahoo.com.cn</email>
				<xref ref-type="aff" rid="I1">
					<sup>1</sup>
				</xref>
			</contrib>
			<contrib contrib-type="author" id="U40878605">
				<name>
					<surname>Li</surname>
					<given-names>Jing</given-names>
				</name>
				<email>natashalee@163.com</email>
				<xref ref-type="aff" rid="I4">
					<sup>4</sup>
				</xref>
			</contrib>
		</contrib-group>
		<aff id="I1">
			<sup>1</sup>
			<addr-line>Department of Pharmacology</addr-line>
			<addr-line>Institute of Clinical Medical Sciences</addr-line>
			<addr-line>China-Japan Friendship Hospital</addr-line>
			<addr-line>No. 2 Yinghua Dongjie</addr-line>
			<addr-line>Hepingli</addr-line>
			<addr-line>Beijing 100029</addr-line>
			<country>China</country>
			<ext-link ext-link-type="domain-name">zryhyy.com.cn</ext-link>
		</aff>
		<aff id="I2">
			<sup>2</sup>
			<addr-line>Faculty of Pharmacy</addr-line>
			<addr-line>University of Manitoba</addr-line>
			<addr-line>750 McDermot Avenue</addr-line>
			<addr-line>Winnipeg, MB</addr-line>
			<country>Canada</country>
			<addr-line>R3E 0T5</addr-line>
			<ext-link ext-link-type="domain-name">umanitoba.ca</ext-link>
		</aff>
		<aff id="I3">
			<sup>3</sup>
			<addr-line>Faculty of Medicine</addr-line>
			<addr-line>University of Manitoba</addr-line>
			<addr-line>750 McDermot Avenue</addr-line>
			<addr-line>Winnipeg, MB</addr-line>
			<country>Canada</country>
			<addr-line>R3E 0T5</addr-line>
			<ext-link ext-link-type="domain-name">umanitoba.ca</ext-link>
		</aff>
		<aff id="I4">
			<sup>4</sup>
			<addr-line>Dongzhimen Hospital</addr-line>
			<addr-line>Beijing University of Chinese Medicine</addr-line>
			<addr-line>No. 5 Hai Yun Cang, Dongcheng District</addr-line>
			<addr-line>Beijing 100700</addr-line>
			<country>China</country>
			<ext-link ext-link-type="domain-name">bucm.edu.cn</ext-link>
		</aff>
		<pub-date pub-type="publication-year">
			<year>2011</year>
		</pub-date>
		<pub-date pub-type="archival-date">
			<day>17</day>
			<month>1</month>
			<year>2011</year>
		</pub-date>
		<volume>2011</volume>
		<history>
			<date date-type="received">
				<day>21</day>
				<month>07</month>
				<year>2010</year>
			</date>
			<date date-type="rev-recd">
				<day>22</day>
				<month>11</month>
				<year>2010</year>
			</date>
			<date date-type="accepted">
				<day>13</day>
				<month>12</month>
				<year>2010</year>
			</date>
		</history>
		<permissions>
			<copyright-year>2011</copyright-year>
			<copyright-holder>Copyright © 2011 Haojun Zhang et al.</copyright-holder>
			<license license-type="open-access">
				<license-p>This is an open access article distributed under the <ext-link xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
			</license>
		</permissions>
		<abstract>
			<p>Diabetic nephropathy is one of the most significant microvascular complications in patients with type 2 diabetics. The concise mechanism of diabetic nephropathy is unknown and there is no successful treatment. The objective of study was to investigate effects of Chinese herbs (Tangshen Formula) on diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. OLETF rats and LETO rats were divided into four groups: LETO control, OLETF diabetics, OLETF diabetics treated with Tangshen Formula, and OLETF diabetics treated with Monopril. Body weight, blood glucose, and 24 h urinary proteins were measured once every four weeks. Blood samples and kidney tissues were obtained for analyses of total cholesterol, triglyceride, whole blood viscosity, plasma viscosity, and pathohistological examination at 36 and 56 weeksrespectively. Untreated OLETF rats displayed diabetic nephropathy over the study period. Treatment of OLETF rats with Tangshen Formula attenuated the increases in blood glucose, body weight, 24 h urinary protein content, serum total cholesterol, whole blood viscosity and plasma viscosity at certain time. Treatment with Tangshen Formula also reduced glomerulosclerotic index and interstitial fibrotic index seen in OLETF rats. In conclusion, Tangshen Formula could attenuate the development of diabetic nephropathy in OLETF rat diabetic model.</p>
		</abstract>
		<funding-group>
			<award-group>
				<funding-source>National Key project of Basic Research Grant, China</funding-source>
				<award-id>2005CB523503</award-id>
			</award-group>
			<award-group>
				<funding-source>International Collaboration in Science and Technology Grant, China</funding-source>
				<award-id>2006DFB31480</award-id>
			</award-group>
			<award-group>
				<funding-source>Key Project of National Natural Fund China</funding-source>
				<award-id>90709045</award-id>
			</award-group>
		</funding-group>
		<counts>
			<ref-count count="38"/>
			<page-count count="8"/>
		</counts>
	</article-meta>
</front>
